Amid continuing rumors about an IPO, Avadim Technologies has raised another $250,000.

In other SEC filing news, a Winston-Salem biotech looks to raise money and the founder of CommScope sells $10 million in shares.

The details:

  • Avadim Technologies sells $215,000 in equity

Asheville-based Avadim Technologies Inc., a life sciences company, raised $251,154 in equity financing amidst rumors the company plans to go public.

Avadim Technologies filed a Form D, signed by president David Fann, with the Securities and Exchange Commission on Dec. 28.

The total offering amount represents the price of 59,095 shares at $4.25 per share issued pursuant to a private placement.

In the past two months, Avadim raised more than $3.2 million in private stock offerings and $580,000 in equity financing, the North Carolina Business News Wire reports.

Avadim sells specialty skin hygiene products, such as pH-balanced, no-rinse skin cleansers, to health care providers and consumers. The company plans to offer products in major drug stores such as CVS and Walgreen’s by the end of 2017.

Avadim was founded in 2007 in Asheville.

In September, Avadim announced plans to expand operations in Buncombe County, building a new 100,000 square foot corporate headquarters in Black Mountain Commerce Park and adding 551 jobs. The company plans to invest $25.4 million in the new facility over the next five years.

  • Winston-Salem biotech firm seeks $1.25 million

KeraNetics, a biotechnology company based in Winston-Salem wants to raise $1.25 million in a private offering, according to a Securities and Exchange Commission filing.

Of the $1.25 million, KeraNetics LLC plans to use $275,000 for to pay for the salary for its CEO and managing director.

KeraNetics develops and manufactures purified keratin medical products, which are used to treat burn victims and for muscle regeneration. Last year, it received a $1 million contract from the U.S. Department of Defense for pre-clinical testing and a safety trial of KeraGenics Muscle for the treatment of volumetric muscle loss.

The company holds patents for methods of purifying keratin proteins and for fields of use in regenerative medicine and trauma.

The company’s chief executive officer is Kim Westmoreland, who has has over 25 years of experience as a serial entrepreneur and has founded six start-up companies including KeraNetics. Westmoreland is the former assistant dean of the Wake Forest University School of Business.

  • CommScope founder, chairman sells $10 million in stock

Frank Drendel, the founder and current chairman of CommScope Holding Co., recently sold more than $10.2 million in company stock.

Drendel, who founded the telecommunications equipment company in 1976, sold more than 280,000 shares in 10 transactions on Dec. 16 and Dec. 19 at prices ranging from $36.59 to $36.79.

According to the Dec. 20 filing with the Securities and Exchange Commission, Drendel still owns more than 2.3 million shares worth approximately $85 million.

Drendel has been chairman of the board since the company was acquired by private equity firm Carlyle Group Inc. in 2011 for $3.9 billion. CommScope has since gone public again, and Carlyle has sold its remaining stock in the company earlier this year.

Drendel was chairman and CEO from 1976 until the Carlyle acquisition. Drendel is a director of the National Cable & Telecommunications Association, the principal trade association of the cable industry in the United States, and was inducted into the Cable Television Hall of Fame in 2002.